Publications
- Sustainability of biologic treatment in paediatric patients with Crohn's disease: population-based registry analysis2024 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease2023 | Second Faculty of Medicine
- Adalimumab versus infliximab in pediatric patients with Crohn's disease: A propensity-score analysis and predictors of treatment escalation2022 | Second Faculty of Medicine
- Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn's Disease on Combination Therapy? A Multicenter Prospective Observational Study2021 | First Faculty of Medicine, Second Faculty of Medicine
- Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn's disease2021 | Second Faculty of Medicine
- Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease2018 | Second Faculty of Medicine
- Musculoskeletal system in children and adolescents with inflammatory bowel disease: normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fractures2017 | Second Faculty of Medicine
- Supplementation with 2000 IU of Cholecalciferol Is Associated with Improvement of Trabecular Bone Mineral Density and Muscle Power in Pediatric Patients with IBD2017 | Second Faculty of Medicine
- Importance of faecal calprotectin in screening and clinical assessment of adult and pediatric patients with inflammatory bowel diseases2016 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors +1First Faculty of Medicine, Second Faculty of Medicine
Loading network view...